Drug Shortage Report for HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG
| Report ID | 140892 |
| Drug Identification Number | 02125323 |
| Brand name | HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG |
| Common or Proper name | HYDROmorphone hydrochloride Controlled Release Capsules |
| Company Name | PURDUE PHARMA |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
| Strength(s) | 3MG |
| Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 60 |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2021-06-15 |
| Actual start date | 2021-06-15 |
| Estimated end date | 2021-07-05 |
| Actual end date | 2021-07-05 |
| Shortage status | Resolved |
| Updated date | 2021-07-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v13 | 2021-07-06 | English | Compare |
| v12 | 2021-07-05 | French | Compare |
| v11 | 2021-07-05 | English | Compare |
| v10 | 2021-06-30 | French | Compare |
| v9 | 2021-06-30 | English | Compare |
| v8 | 2021-06-30 | French | Compare |
| v7 | 2021-06-30 | English | Compare |
| v6 | 2021-06-30 | English | Compare |
| v5 | 2021-06-23 | French | Compare |
| v4 | 2021-06-23 | English | Compare |
| v3 | 2021-06-16 | English | Compare |
| v2 | 2021-06-14 | French | Compare |
| v1 | 2021-06-14 | English | Compare |
Showing 1 to 13 of 13